Adam Elhofy
- Neurology top 5%
- Immunology top 5%
- Immune cells in cancer 7
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- interferon and immune responses 2
- Microbiology top 10%
-
- Chemokine receptors and signaling 6
-
- Multiple Sclerosis Research Studies 2
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- William J. KarpusStephen D. MillerWendy Smith BegolkaJulie K. OlsonPamela A. CarpentierKenneth L. BostIan MarriottMike J. Mason
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (2 papers)The Journal of Immunology (3 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Adam Elhofy
23 papers receiving 819 citations
Peers
Comparison fields: 5 of 83
- Neurology 265
- Immunology 472
- Biological Psychiatry 26
- Developmental Neuroscience 32
- Microbiology 42
Countries citing papers authored by Adam Elhofy
This map shows the geographic impact of Adam Elhofy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Elhofy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Elhofy more than expected).
Fields of papers citing papers by Adam Elhofy
This network shows the impact of papers produced by Adam Elhofy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Elhofy. The network helps show where Adam Elhofy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam Elhofy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 4 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 17 | |
| 8 | 2020 | 3 | |
| 9 | 2016 | 3 | |
| 10 | 2009 | 60 | |
| 11 | 2007 | 22 | |
| 12 | 2004 | 305 | |
| 13 | 2003 | 15 | |
| 14 | 2003 | 30 | |
| 15 | 2002 | 29 | |
| 16 | 2001 | 51 | |
| 17 | 2000 | 11 | |
| 18 | 2000 | 89 | |
| 19 | 1999 | 24 | |
| 20 | 1998 | 21 |
About Adam Elhofy
Adam Elhofy is a scholar working on Immunology, Oncology and Toxicology, having authored 23 papers that have together received 829 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Chemokine receptors and signaling (6 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), interferon and immune responses (2 papers), Multiple Sclerosis Research Studies (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Neurology (265 citations), Immunology (472 citations) and Biological Psychiatry (26 citations). Adam Elhofy has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include William J. Karpus, Stephen D. Miller, Wendy Smith Begolka, Julie K. Olson, Pamela A. Carpentier, Kenneth L. Bost, Ian Marriott, Mike J. Mason, Jami Bennett and J. Kent Ellington. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.